INVENTORY IMPAIRMENT AND WRITE-DOWN	6 Months Ended
Jun. 30, 2026
INVENTORY IMPAIRMENT AND WRITE-DOWN
INVENTORY IMPAIRMENT AND WRITE-DOWN	NOTE 4 – INVENTORY IMPAIRMENT AND WRITE-DOWN Based on management’s evaluation, inventories totaling $174,745 expired in January 2026. In accordance with regulatory and commercial compliance standards regarding expired health supplements, this inventory no longer possessed recoverable commercial value. Therefore, a loss on inventory impairment and an allowance for inventory obsolescence were recorded as of December 31, 2025. On February 8, 2026, the Board of Directors authorized the full impairment and write-down of inventory.

The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 330
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/330/tableOfContent

Name:	us-gaap_InventoryDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration